CWP
TEVA icon

Capital Wealth Planning’s Teva Pharmaceuticals TEVA Stock Holding History

Capital Wealth Planning’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20,000
Closed -$1K – 238
2019
Q3 		$1K Sell
20,000
-5,000
-20% -$38.3K ﹤0.01% 262
2019
Q2 		$6K Buy
+25,000
New +$301K ﹤0.01% 258

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Wealth Planning's TEVA Position: Q1 2026 in Review

Capital Wealth Planning opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 525,000 shares worth $15.8M. The stake represents 0.09% of the portfolio and ranks #75 among its holdings. This is a return to the name: Capital Wealth Planning previously reported a position in TEVA as recently as Q4 2024.

Capital Wealth Planning first reported a position in TEVA in Q2 2019 and has held it in 13 quarters since. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Capital Wealth Planning held 525,000 shares of Teva Pharmaceuticals worth $15.8M as of Q1 2026.
  • Teva Pharmaceuticals was a new Capital Wealth Planning position in Q1 2026.
  • Teva Pharmaceuticals made up 0.09% of Capital Wealth Planning's portfolio in Q1 2026, its #75 holding.
  • Capital Wealth Planning first reported a position in Teva Pharmaceuticals in Q2 2019 and has held it in 13 quarters since.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Capital Wealth Planning's 13F filing for Q1 2026, filed 15 May 2026.